Watchlist Price Alert

BioCryst Pharmaceuticals ... (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

10.00

-0.29 (-2.82%)

At close: Jun 17, 2025, 10:20 AM

BioCryst Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-88.88M	-226.54M	-247.12M	-184.06M	-182.81M	-108.9M	-101.25M	-65.78M	-55.14M
Depreciation & Amortization	1.25M	1.66M	1.44M	777K	748K	724K	770K	704K	483K
Stock-Based Compensation	65.41M	55.62M	44.7M	34.64M	14.79M	17.72M	9.4M	12.62M	8.49M
Other Working Capital	n/a	-8.05M	-2.69M	1.28M	-1.97M	1.9M	-6.94M	2.33M	4.39M
Other Non-Cash Items	57.48M	106.53M	98.07M	-1.64M	5.29M	1.28M	885K	876K	558K
Deferred Income Tax	n/a	n/a	n/a	-55.84M	n/a	464K	1.17M	1.11M	-271K
Change in Working Capital	-87.28M	-32.4M	-58.95M	8.12M	26.88M	-872K	-3.53M	9.33M	-7.55M
Operating Cash Flow	-52.02M	-95.14M	-161.85M	-142.16M	-135.11M	-89.58M	-92.56M	-41.14M	-53.44M
Capital Expenditures	-1.12M	-2.17M	-1.35M	-2.38M	-514K	-343K	-366K	-328K	-5.28M
Cash Acquisitions	n/a	n/a	1.35M	2.38M	513K	366K	366K	12K	4K
Purchase of Investments	-266.76M	-514.41M	-244.28M	-10.01M	-49.82M	-3.02M	-62.61M	-107.79M	-14.11M
Sales Maturities Of Investments	320.48M	385.08M	117.4M	28.2M	43.48M	81.3M	67.75M	43.46M	42.65M
Other Investing Acitivies	-1.12M	n/a	-1.35M	n/a	-513K	-366K	-366K	-1.74M	66K
Investing Cash Flow	52.59M	-131.5M	-128.24M	15.8M	-6.86M	77.93M	4.77M	-66.38M	23.34M
Debt Repayment	-1.7M	58.38M	73.07M	293.87M	67.45M	19.48M	6.25M	122K	22.99M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.09M	-25.9M	14.77M	15.73M	141.97M	21.12M	2.85M	1.58M	317K
Financial Cash Flow	-5.76M	32.48M	88.03M	359.67M	300.59M	99.1M	62.5M	135.7M	23.3M
Net Cash Flow	-6.12M	-193.79M	-201.5M	233.39M	158.63M	87.45M	-25.29M	28.18M	-6.79M
Free Cash Flow	-53.14M	-97.31M	-163.2M	-144.54M	-137.73M	-89.93M	-92.93M	-41.47M	-58.72M